Showing results (401-410 of 587) with videos related to
Sort By:
Pageof 59
European Journal of Cancer (Oxford, England : 1990)|December 14, 2020
Impact of expert pathologic review of thymic epithelial tumours on diagnosis and management in a real-life setting: A RYTHMIC studyThierry J Molina, Maria V Bluthgen, Lara Chalabreysse, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2022
Combination of Trastuzumab, Pertuzumab, and Docetaxel in Patients With Advanced Non-Small-Cell Lung Cancer Harboring HER2 Mutations: Results From the IFCT-1703 R2D2 TrialJulien Mazieres, Claire Lafitte, Charles Ricordel, et al.International Journal of Cancer|August 15, 2024
Clinical and molecular features of early onset pancreatic adenocarcinomaMaxime Rémond, Cristina Smolenschi, Anthony Tarabay, et al.Pathology|June 4, 2024
Successive next-generation sequencing strategy for optimal fusion gene detection in non-small-cell lung cancer in clinical practiceSimon Garinet, Audrey Lupo, Thomas Denize, et al.European Journal of Cancer (Oxford, England : 1990)|September 25, 2023
Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncologyEmily Alouani, Ariane Laparra, Audrey Perret, et al.Nature Communications|December 4, 2018
Human preprocalcitonin self-antigen generates TAP-dependent and -independent epitopes triggering optimised T-cell responses toward immune-escaped tumoursAurélie Durgeau, Yasemin Virk, Gwendoline Gros, et al.Cancers|February 25, 2023
Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract CarcinomaPauline Parent, Edouard Auclin, Anna Patrikidou, et al.Plos One|April 3, 2026
PRognostic and predictive potential Of multiparametric dynamic whole-body 18F-FDG PET Imaging using a Long axial field-of-view (LAFOV) system for FIRST-line chemo-immunotherapy efficacy in advanced non-small cell lung cancer: PROFIL-1 study protocolMargaux Geier, Karim Amrane, David Bourhis, et al.BMC Cancer|July 17, 2016
Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancerMathieu Rouanne, Julien Adam, Aïcha Goubar, et al.NPJ Precision Oncology|February 16, 2024
EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancersMarco Tagliamento, Marie Morfouace, Charalambos Loizides, et al.Pageof 59